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ABSTRACT
Objectives: Laparoscopic splenectomy has been increas-
ingly used in patients with idiopathic thrombocytopenic pur-
pura. Because it is associated with minimal abdominal
trauma, platelet consumption could be reduced with the
laparoscopic approach. The aim of this study was to analyze
intraoperative bleeding and the need for apheresis platelets,
comparing laparoscopic with open splenectomy.
Methods: Records of 40 patients who underwent sple-
nectomy (20 through laparoscopy and 20 through open
surgery) for idiopathic thrombocytopenic purpura were
retrospectively reviewed. Intraoperative bleeding and
need of perioperative apheresis platelets were evaluated
in both groups. Statistical evaluation was conducted using
the Mann-Whitney rank test, and differences were consid-
ered significant at P0.01.
Results: The mean amount of intraoperative bleeding was
less in the laparoscopic group (P0.01). Apheresis plate-
lets were necessary in all patients in the open group (2
units transfused in 55% and 1 unit in 45% of cases) and
only in 30% of cases in the laparoscopic group (1 unit
transfused in each case).
Conclusions: Laparoscopic splenectomy is a safe proce-
dure also in patients at high risk for bleeding diathesis. In
idiopathic thrombocytopenic purpura, laparoscopic sple-
nectomy should be the gold-standard surgical treatment.
Need of platelet transfusion is probably reduced when
laparoscopic splenectomy is compared with open surgery
in these patients.
Key Words: Laparoscopic splenectomy, Idiopathic
thrombocytopenic purpura, Apheresis platelets, Platelet
transfusion.
INTRODUCTION
Laparoscopic splenectomy has been increasingly used for
removal of the spleen in patients with idiopathic throm-
bocytopenic purpura (ITP) refractory to medical treat-
ment.1 Since its introduction in 1992,2 several studies have
been published pointing out the safety of the procedure
and the advantages, such as shorter hospital stay, less
postoperative pain, and fewer complications.3,4 Other
studies have compared the therapeutic response of lapa-
roscopic versus open splenectomy, with contradictory re-
sults.5–7
Because laparoscopic splenectomy is associated with less
abdominal trauma, operative platelet consumption and
therefore need of platelet transfusion may be reduced
during laparoscopy compared with open surgery. How-
ever, no data exist in this regard at this time. In this study,
we evaluated in a retrospective analysis differences in
intraoperative bleeding and the need for platelet transfu-
sion comparing laparoscopic and open splenectomy.
METHODS
The records of 40 patients, who underwent splenectomy
for ITP from 1994 to 2002, were reviewed. In 20 patients
(study group), the spleen was removed laparoscopically,
whereas in the other 20 patients (historical control group)
splenectomy was performed by open surgery. In both
groups, the same surgeon (RV) performed splenectomy,
and enrollment in the laparoscopic or open group was
determined according to the patient’s choice.
Data assessed for each group are reported in Table 1. The
median age of the patients was similar in both groups. The
male-to-female ratio was also comparable. Preoperative
median platelet counts were not statistically different. Al-
ternative causes of thrombocytopenia were accurately
ruled out before any medical or surgical treatment in these
patients. All patients were previously treated with cortico-
steroids (prednisone 1 mg/Kg/die) for 4 months to 6
months before surgery. Splenectomy was indicated in
cases refractory to medical treatment or relapsing at the
interruption of corticosteroid therapy. All patients were
symptomatic with various degrees of mucocutaneous
bleeding when surgery was proposed. In these series,
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SCIENTIFIC PAPERpreoperative infusion of intravenous IgV was not per-
formed in any patient.
Open splenectomy was performed in the traditional fash-
ion.1 Through a midline abdominal incision, short gastric
vessels were accurately identified and divided. Splenic
artery and vein were ligated and divided. Splenic hilum,
tail of the pancreas, splenocolic and gastrosplenic liga-
ments, omentum, and paraduodenal area were always
checked for accessory spleens, which were found in 2
patients (10%) in this series. Laparoscopic splenectomies
were performed with patients lying in the right lateral
position (left flank elevated about 45° above the operating
table). A Hasson trocar was inserted in the upper umbil-
ical region, and 3 other trocars were placed in the subxy-
phoid area (10 mm), lower left midclavicular line below
the umbilical line (10 mm), and lower left axillary line (5
mm). With a 30° scope, after dissection of the spleno-colic
ligament, division of the gastrosplenic ligament with the
short gastric vessels was accomplished by using the ultra-
sonic dissector (Ultracision Harmonic Scalpel, Ethicon En-
dosurgery, Inc., Cincinnati, OH, USA). The convex surface
of the spleen was then accurately dissected from the
lateral abdominal wall and from the diaphragm; at this
point, the splenic hilum was approached from the anterior
aspect, and the splenic artery and veins were clipped and
divided. The spleen was then inserted in a plastic bag that
was pulled through the abdominal umbilical access. The
spleen was then crushed and removed, care being taken
to prevent bag lacerations and splenic fragment peritoneal
implantation (splenosis). Like in the open approach, sites
of accessory spleen were accurately scoped, and this al-
lowed their identification and removal in 3 patients (15%)
in this study group.
Results were evaluated comparing intraoperative bleeding
and the need for perioperative platelet transfusion in the
2 groups. Platelets were transfused with apheresis plate-
lets and were administered to the patients when the sur-
geon noted intraoperative bleeding from the cut surface
without any evidence of damaged vessel. Statistical eval-
uation was conducted using the Wilcoxon rank sum test.
Differences were considered statistically significant at
P0.01.
RESULTS
No intraoperative or postoperative complications oc-
curred in either group. Data for each parameter evaluated
in this study are reported in Tables 2 and 3. The mean
amount of operative bleeding was 45.510.1 (median, 40;
range, 0 to 150) in the laparoscopic group compared with
91.58.1 (median, 80; range, 0 to 150) in the open sple-
nectomy group (P0.01). Considering the number of pa-
tients who received platelet transfusion, in the open group
100% of the patients had apheresis platelets transfused,
compared with only 30% in the laparoscopic group. In the
open group, 55% of patients needed 1 unit and 45% 2
units. All patients who needed platelet transfusion in the
laparoscopic group received only 1 unit of apheresis
platelets. No postoperative bleeding was observed in any
patient in either group.
DISCUSSION
Steroid therapy and splenectomy are the most effective
treatment options in patients with ITP. Steroid therapy is
curative in about 50% of these patients,8 but definitive
remission of the disease has been described in only 20% to
25% of the treated cases.1,9,10 Splenectomy is indicated in
patients who do not respond to medical therapy, in pa-
tients relapsing at the withdrawal of steroid therapy, when
steroid therapy is contraindicated, or in cases with low
compliance to prolonged medical treatment.
Since its introduction in 1992,2 laparoscopic splenectomy
has been gaining increasing attention in several centers
for removal of the spleen, especially for benign hemato-
logical disorders. ITP is the most common indication for
laparoscopic splenectomy in several series reported in the
literature,11–18 probably because of the less challenging
operative technique due to the absence of splenomegaly
Table 1.
Patient Data: Open Versus Laparoscopic Splenectomy
Open Laparoscopic
Age (range) (yrs) 19 to 30 18 to 27
Sex ratio (M/F) 1:3 1:3
Mean preoperative platelet count (range) 15  10
9/L (3 to 30) 18  10
9/L (3 to 27)
Mean months of preoperative corticosteroid therapy (range) 6 (2 to 8) 4 (2 to 7)
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura, Vecchio R et al.
JSLS (2005)9:415–418 416in these patients. Laparoscopic splenectomy can be per-
formed safely in ITP patients, despite thrombocytopenia,
and is associated with decreased hospital stay, shorter
time to recovery, and lower hospital charges compared
with those in open approach.19,20
The laparoscopic approach also allows complete visual-
ization of sites where accessory spleens are located,
whose removal is essential for the curative effects of
splenectomy in patients with ITP. With laparoscopic tech-
niques, the splenic hilum, tail of the pancreas, splenocolic
and gastrosplenic ligaments, omentum, and paraduodenal
area can be easily checked for accessory spleens, which
are present in 18% to 95% of ITP patients.12–14 Because it
lacks tactile feedback, to improve the success of laparos-
copy in detecting small accessory spleens, in recent re-
ports some authors have recommended using an intraop-
erative gamma probe.21
In addition, laparoscopy could be responsible for hema-
tological benefits. Only a few studies, however, have
addressed this issue. In spite of a few contradictory re-
ports, most clinical and experimental22 studies support the
view that laparoscopic surgery is associated with better
preservation of postoperative systemic immune function
than is open surgery. Several other clinical studies have
shown that laparoscopic surgery may induce fewer throm-
bogenic changes than traditional surgery does, although
deep vein thrombosis can still occur after laparoscopy,
and its prevention is mandatory in mini-invasive proce-
dures.23 No study has been published with regard to
platelet consumption in laparoscopic surgery. The lesser
extent of tissue trauma with laparoscopy, which seems to
be the key factor for the immunological and coagulative
differences compared with those of open surgery, could
induce a lower consumption of platelets. With laparos-
copy, it can be supposed that use of platelets for hemo-
stasis of small vessels in the cut surface, especially in the
abdominal wall, is less pronounced and therefore their
consumption is reduced. Our study seems to confirm this
hypothesis. In our study, in patients whose spleen had
been removed laparoscopically, surface bleeding during
the dissection of the spleen from its attachments appeared
less important than in open surgery and almost never
required intraoperative transfusion of platelets. In our
opinion, this could be explained by the fact that circulat-
Table 2.
Intraoperative Bleeding: Open Versus Laparoscopic Splenectomy
Table 3.





Percent of patients transfused 100 30
Units transfused (% pts) 1 U (55) 1 U (30)
2 U (45)
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the operation and used by the organism when they oc-
curred for hemostasis in dissection of the spleen, resulting
in less bleeding during the intraabdominal phase of the
procedure. The use of the Harmonic scalpel might also
play an additional role in the reduced intraoperative
bleeding during laparoscopy. In the laparoscopic group of
this study, intraoperative bleeding was less significant,
with P0.01, than in the open surgery group and the need
for apheresis platelets was lower, as judged by the sur-
geons during the operation.
CONCLUSION
Laparoscopic splenectomy is a safe procedure in patients
with a high risk of bleeding diathesis. In ITP patients, the
laparoscopic approach for removal of the spleen should
be the gold-standard surgical treatment. Need for platelet
transfusion is probably reduced when laparoscopic sple-
nectomy is compared with open surgery in these patients.
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